Cardiovascular Systems, Inc. (CSII)

Market Cap	572.53M
Revenue (ttm)	237.53M
Net Income (ttm)	-38.95M
Shares Out	41.88M
EPS (ttm)	-0.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	227,086
Open	14.66
Previous Close	14.72
Day's Range	13.64 - 14.70
52-Week Range	12.26 - 23.47
Beta	0.84
Analysts	Buy
Price Target	20.40 (+49.12%)
Earnings Date	Feb 9, 2023

About CSII

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Co...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 26, 2009
• Employees: 725
• Stock Exchange: NASDAQ
• Ticker Symbol: CSII

Financial Performance

In 2022, CSII's revenue was $236.22 million, a decrease of -8.79% compared to the previous year's $258.97 million. Losses were -$36.93 million, 175.2% more than in 2021.

Analyst Forecast

According to 14 analysts, the average rating for CSII stock is "Buy." The 12-month stock price forecast is $20.4, which is an increase of 49.12% from the latest price.

Price Target

$20.4

(49.12% upside)

Analyst Consensus: Buy